{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T05:48:46Z","timestamp":1661665726664},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/cad.0000000000000097","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T20:50:40Z","timestamp":1393879840000},"page":"729-734","source":"Crossref","is-referenced-by-count":4,"title":["Increase in triglyceride blood level in patients treated with capecitabine"],"prefix":"10.1097","volume":"25","author":[{"given":"Gil","family":"Bar-Sela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit","family":"Cohensius-Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Vornikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nissim","family":"Haim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/bjc.2011.52","article-title":"Severe hypertriglyceridemia during treatment with capecitabine.","volume":"104","author":"Javot","year":"2011","journal-title":"Br J Cancer"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/02841869509093964","article-title":"Influence of 5-fluorouracil on serum lipids.","volume":"34","author":"Stathopoulos","year":"1995","journal-title":"Acta Oncol (Madr)"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00280-008-0799-2","article-title":"Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.","volume":"63","author":"Bar-Sela","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1078155209344650","article-title":"Case report capecitabine-induced pancreatitis.","volume":"16","author":"Yucel","year":"2010","journal-title":"J Oncol Pharm Pract"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1464-5491.2009.02842.x","article-title":"Capecitabine-induced severe hypertriglycaemia and diabetes: a case report and review of the literature.","volume":"26","author":"Garg","year":"2009","journal-title":"Diabetic Med"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.bjc.6605807","article-title":"The frequency and severity of capecitabine-induced hypertriglyceridemia in routine clinical practice: a prospective study.","volume":"103","author":"Michie","year":"2010","journal-title":"Br J Cancer"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1179\/1973947813Y.0000000072","article-title":"Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine.","volume":"25","author":"Geva","year":"2013","journal-title":"J Chemother"},{"key":"R13-14-20210203","first-page":"2249","article-title":"Capecitabine-induced hypertriglyceridemia: a report of two cases.","volume":"26","author":"Koutras","year":"2006","journal-title":"Anticancer Res"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1345\/aph.1G348","article-title":"Capecitabine-induced severe hypertriglyceridemia: report of two cases.","volume":"40","author":"Kurt","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/02841860903373708","article-title":"Hypertriglyceridemia: an under diagnosed side effect of capecitabine chemotherapy.","volume":"49","author":"Orphanos","year":"2010","journal-title":"Acta Oncol (Madr)"},{"key":"R16-14-20210203","first-page":"104","article-title":"Severe hypertriglyceridemia associated with the use of capecitabine.","volume":"70","author":"Polinder-Bos","year":"2012","journal-title":"Neth J Med"},{"key":"R17-14-20210203","first-page":"1653","article-title":"Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.","volume":"27","author":"Stathopoulos","year":"2007","journal-title":"Anticancer Res"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/jcem.83.5.4753","article-title":"Effect of tamoxifen on serum lipid metabolism.","volume":"83","author":"Hozumi","year":"1998","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:54Z","timestamp":1620946914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201407000-00014"}},"subtitle":["a retrospective survey"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000097","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}